Search
forResearch 10 of 1000+
- Natural variability and the influence of concurrent control values on the detection and interpretation of low-dose or weak endocrine toxicities.
- Problems Associated with the Recognition and Confirmation of Low-Dose Endocrine Toxicities
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- 44391 ICI Therapy Toxicities in Psoriasis
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- The Many Faces of Calcineurin Inhibitor Toxicity—What the FK?
- Management of the adverse effects of targeted therapy for cancer
- Alopecia With Endocrine Therapies in Patients With Cancer
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →